↓ Skip to main content

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years

Overview of attention for article published in New England Journal of Medicine, November 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
170 news outlets
blogs
4 blogs
policy
3 policy sources
twitter
323 X users
patent
2 patents
facebook
22 Facebook pages
googleplus
2 Google+ users
reddit
1 Redditor

Citations

dimensions_citation
1194 Dimensions

Readers on

mendeley
1061 Mendeley
citeulike
3 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
Published in
New England Journal of Medicine, November 2017
DOI 10.1056/nejmoa1701830
Pubmed ID
Authors

Hongchao Pan, Richard Gray, Jeremy Braybrooke, Christina Davies, Carolyn Taylor, Paul McGale, Richard Peto, Kathleen I Pritchard, Jonas Bergh, Mitch Dowsett, Daniel F Hayes

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 323 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 1,061 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 1061 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 133 13%
Student > Ph. D. Student 123 12%
Student > Master 94 9%
Other 85 8%
Student > Bachelor 78 7%
Other 174 16%
Unknown 374 35%
Readers by discipline Count As %
Medicine and Dentistry 318 30%
Biochemistry, Genetics and Molecular Biology 128 12%
Agricultural and Biological Sciences 43 4%
Pharmacology, Toxicology and Pharmaceutical Science 30 3%
Nursing and Health Professions 22 2%
Other 95 9%
Unknown 425 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1490. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 September 2024.
All research outputs
#8,575
of 26,746,546 outputs
Outputs from New England Journal of Medicine
#435
of 33,247 outputs
Outputs of similar age
#119
of 347,230 outputs
Outputs of similar age from New England Journal of Medicine
#9
of 274 outputs
Altmetric has tracked 26,746,546 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 33,247 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 124.3. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 347,230 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 274 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.